These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17199081

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B, Levin L.
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
    Rodrigues A, Cabrita A, Maia P, Guimarães S.
    Adv Perit Dial; 2002 Jun; 18():78-80. PubMed ID: 12402593
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ, Kim YL, Park SH, Kim CD, Kim JC, Jang MH, Choi HJ.
    Adv Perit Dial; 2005 Jun; 21():25-30. PubMed ID: 16686280
    [Abstract] [Full Text] [Related]

  • 12. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
    Nakamura S, Tachikawa T, Tobita K, Miyazaki S, Sakai S, Morita T, Hirasawa Y, Weigle B, Pischetsrieder M, Niwa T.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
    [Abstract] [Full Text] [Related]

  • 13. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V, Limardo M, Cavalli A, Crepaldi M, Locatelli F.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Influence of ligustrazine-contained peritoneal dialysate on efficiency of dialysis].
    Lu C, Ye R, Sun L.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Dec; 18(12):709-11. PubMed ID: 11475713
    [Abstract] [Full Text] [Related]

  • 17. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [Abstract] [Full Text] [Related]

  • 18. Scrotal edema secondary to fluid imbalance in patients on continuous peritoneal dialysis.
    Adeniyi M, Wiggins B, Sun Y, Servilla KS, Hartshorne MF, Tzamaloukas AH.
    Adv Perit Dial; 2009 Sep; 25():68-71. PubMed ID: 19886320
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
    Sezer S, Elsurer R, Afsar B, Arat Z, Ozdemir NF, Haberal M.
    Nephron Clin Pract; 2007 Sep; 107(4):c156-62. PubMed ID: 17957127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.